COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
NYSE:CYH - New York Stock Exchange, Inc. - US2036681086 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to CYH. CYH was compared to 103 industry peers in the Health Care Providers & Services industry. While CYH is still in line with the averages on profitability rating, there are concerns on its financial health. CYH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CYH had negative earnings in the past year.
In the past year CYH had a positive cash flow from operations.
In multiple years CYH reported negative net income over the last 5 years.
CYH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CYH's Return On Assets of -3.51% is on the low side compared to the rest of the industry. CYH is outperformed by 63.11% of its industry peers.
CYH's Return On Invested Capital of 5.86% is fine compared to the rest of the industry. CYH outperforms 61.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CYH is below the industry average of 9.71%.
The 3 year average ROIC (5.27%) for CYH is below the current ROIC(5.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.51% | ||
| ROE | N/A | ||
| ROIC | 5.86% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
Looking at the Operating Margin, with a value of 6.76%, CYH is in the better half of the industry, outperforming 70.87% of the companies in the same industry.
CYH's Operating Margin has been stable in the last couple of years.
The Gross Margin of CYH (84.61%) is better than 97.09% of its industry peers.
CYH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.76% | ||
| PM (TTM) | N/A | ||
| GM | 84.61% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYH is creating some value.
Compared to 1 year ago, CYH has more shares outstanding
CYH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CYH has a worse debt to assets ratio.
2.2 Solvency
CYH has an Altman-Z score of 0.81. This is a bad value and indicates that CYH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CYH (0.81) is worse than 71.84% of its industry peers.
The Debt to FCF ratio of CYH is 74.55, which is on the high side as it means it would take CYH, 74.55 years of fcf income to pay off all of its debts.
CYH has a Debt to FCF ratio of 74.55. This is in the lower half of the industry: CYH underperforms 62.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 74.55 | ||
| Altman-Z | 0.81 |
ROIC/WACC1.06
WACC5.53%
2.3 Liquidity
A Current Ratio of 1.44 indicates that CYH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.44, CYH perfoms like the industry average, outperforming 47.57% of the companies in the same industry.
CYH has a Quick Ratio of 1.30. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, CYH is in line with its industry, outperforming 46.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.36% over the past year.
CYH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.05%.
Measured over the past years, CYH shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)16.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%0.61%
3.2 Future
CYH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.75% yearly.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 2.12% on average per year.
EPS Next Y75.73%
EPS Next 2Y41.56%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue Next Year-1.11%
Revenue Next 2Y1.16%
Revenue Next 3Y2.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
CYH is valuated quite expensively with a Price/Forward Earnings ratio of 844.06.
CYH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CYH is more expensive than 61.16% of the companies in the same industry.
CYH is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 844.06 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CYH indicates a somewhat cheap valuation: CYH is cheaper than 75.73% of the companies listed in the same industry.
99.03% of the companies in the same industry are more expensive than CYH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.15 | ||
| EV/EBITDA | 8.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CYH's earnings are expected to grow with 27.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.56%
EPS Next 3Y27.75%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:CYH (7/3/2025, 11:12:31 AM)
3.41
-0.02 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.69%
Inst Owner Change-0.76%
Ins Owners8.61%
Ins Owner Change4.74%
Market Cap478.46M
Analysts70
Price Target4.27 (25.22%)
Short Float %9.71%
Short Ratio3.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-272.69%
Min EPS beat(2)-607.99%
Max EPS beat(2)62.61%
EPS beat(4)1
Avg EPS beat(4)-161.63%
Min EPS beat(4)-607.99%
Max EPS beat(4)62.61%
EPS beat(8)3
Avg EPS beat(8)-188.26%
EPS beat(12)4
Avg EPS beat(12)-665.99%
EPS beat(16)8
Avg EPS beat(16)-256.1%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.99%
Max Revenue beat(2)2.67%
Revenue beat(4)3
Avg Revenue beat(4)0.92%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.67%
Revenue beat(8)5
Avg Revenue beat(8)0.68%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)8
Avg Revenue beat(16)-0.19%
PT rev (1m)4.69%
PT rev (3m)-0.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-123.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 844.06 | ||
| P/S | 0.04 | ||
| P/FCF | 3.15 | ||
| P/OCF | 0.95 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.55 |
EPS(TTM)-0.92
EYN/A
EPS(NY)0
Fwd EY0.12%
FCF(TTM)1.08
FCFY31.77%
OCF(TTM)3.59
OCFY105.34%
SpS90.19
BVpS-13.71
TBVpS-40.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.51% | ||
| ROE | N/A | ||
| ROCE | 7.42% | ||
| ROIC | 5.86% | ||
| ROICexc | 6.09% | ||
| ROICexgc | 9.25% | ||
| OM | 6.76% | ||
| PM (TTM) | N/A | ||
| GM | 84.61% | ||
| FCFM | 1.2% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score4
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 74.55 | ||
| Debt/EBITDA | 8.49 | ||
| Cap/Depr | 73.95% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 1.04 | ||
| Cash Conversion | 37.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 0.81 |
F-Score4
WACC5.53%
ROIC/WACC1.06
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y75.73%
EPS Next 2Y41.56%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue 1Y (TTM)1.05%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%0.61%
Revenue Next Year-1.11%
Revenue Next 2Y1.16%
Revenue Next 3Y2.12%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year55.28%
EBIT Next 3Y18.15%
EBIT Next 5YN/A
FCF growth 1Y164.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.06%
OCF growth 3YN/A
OCF growth 5Y4.51%